Telmitwin 40/5 mg Tablet

Adult dose

The recommended dose of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). If blood pressure is not controlled, the individual ingredient dosages should be adjusted before switching to this medication. Patients with renal impairment should start with a lower dose in severe cases and gradually increase. Patients with hepatic impairment should not exceed telmisartan 40 mg per day.

Child dose

The safety and efficacy for pediatric patients aged under 18 have not been established, and the use of this medication is not recommended.

This medication can cause serious harm to the fetus if used during pregnancy, particularly in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. This medication should not be administered to individuals with allergies to its active components or dihydropyridine derivatives, or those with severely impaired liver function, severe hypotension, or heart disease. Patients with slightly impaired liver function, gastrointestinal disorders, or kidney diseases should use this medication with greater caution and must be particularly careful if there is any vascular abnormality in the kidneys. During the use of this medication, side effects such as dizziness or edema may occur, and serious side effects may rarely arise; if symptoms develop, immediate consultation with medical personnel is necessary. Do not start this medication during pregnancy, and if pregnancy is confirmed, discontinue it as soon as possible and switch to another safe medication. Patients at risk of hypotension should check their hydration and salt status before starting this medication, and if symptoms of hypotension occur, they should lie down and rest immediately and receive IV therapy if necessary. This medication can increase blood potassium levels, so potassium supplements or potassium-rich foods should be monitored regularly for blood potassium levels when taken together. Patients with impaired kidney function should have their kidney function and electrolyte levels regularly monitored during treatment, and safety in kidney transplant patients has not been established. Patients with heart disease or heart failure need to be careful when taking this medication, especially those with heart failure, as their edema may worsen, and consultation with medical personnel is advised. This medication may cause drowsiness or dizziness, so caution is needed when driving or operating dangerous machinery. Be cautious of potential interactions when taking this medication with other drugs, and inform medical personnel about any current medications, especially lithium, digoxin, warfarin, and non-steroidal anti-inflammatory drugs. This medication contains sorbitol and should not be taken by patients with fructose intolerance. The safety and efficacy for children and adolescents under 18 years have not been sufficiently established, so its use is not recommended. In cases of overdose, symptoms such as hypotension, cardiac arrhythmia, dizziness, and renal failure may occur, so immediate consultation with medical institutions for appropriate treatment is necessary. This medication should be kept out of reach of children and used immediately after opening to avoid moisture.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis.

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light, so it should be stored in an opaque container. Additionally, it should be stored at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.

Appearance

A biconvex oval double tablet that is white and light gray.

Package unit

30 tablets/PTP[(10 tablets/PTP X 3)]